NO20030917D0 - Anvendelse - Google Patents

Anvendelse

Info

Publication number
NO20030917D0
NO20030917D0 NO20030917A NO20030917A NO20030917D0 NO 20030917 D0 NO20030917 D0 NO 20030917D0 NO 20030917 A NO20030917 A NO 20030917A NO 20030917 A NO20030917 A NO 20030917A NO 20030917 D0 NO20030917 D0 NO 20030917D0
Authority
NO
Norway
Prior art keywords
application
Prior art date
Application number
NO20030917A
Other languages
English (en)
Other versions
NO325465B1 (no
NO20030917L (no
Inventor
Einar Sverre Berg
Kjell Skaug
Original Assignee
Kjell Skaug
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kjell Skaug filed Critical Kjell Skaug
Publication of NO20030917D0 publication Critical patent/NO20030917D0/no
Publication of NO20030917L publication Critical patent/NO20030917L/no
Publication of NO325465B1 publication Critical patent/NO325465B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
NO20030917A 2000-08-30 2003-02-27 Anvendelse av ikke-levende liposompartikler inneholdende en intern kontroll-nukleinsyresekvens i nukleinsyrebasert analyse, fremgangsmate for nukleinsyrebasert analyse samt ikke-levende liposompartikler og testsett. NO325465B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021303.3A GB0021303D0 (en) 2000-08-30 2000-08-30 Use
PCT/GB2001/003879 WO2002018635A2 (en) 2000-08-30 2001-08-30 Use of nonviable particles comprising an internal control (ic) nucleic acid

Publications (3)

Publication Number Publication Date
NO20030917D0 true NO20030917D0 (no) 2003-02-27
NO20030917L NO20030917L (no) 2003-04-16
NO325465B1 NO325465B1 (no) 2008-05-05

Family

ID=9898541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030917A NO325465B1 (no) 2000-08-30 2003-02-27 Anvendelse av ikke-levende liposompartikler inneholdende en intern kontroll-nukleinsyresekvens i nukleinsyrebasert analyse, fremgangsmate for nukleinsyrebasert analyse samt ikke-levende liposompartikler og testsett.

Country Status (9)

Country Link
US (2) US20040101869A1 (no)
EP (1) EP1320631A2 (no)
JP (1) JP4504618B2 (no)
AU (2) AU2001284203B2 (no)
CA (1) CA2420845A1 (no)
GB (1) GB0021303D0 (no)
NO (1) NO325465B1 (no)
NZ (1) NZ524881A (no)
WO (1) WO2002018635A2 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003291893A1 (en) * 2002-12-13 2004-07-09 Infectio Diagnostic (I.D.I.) Inc. Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
US7179596B2 (en) * 2003-02-17 2007-02-20 Sceptor Industries, Inc. Biological particulate matter analogue
JP2009512426A (ja) * 2005-10-14 2009-03-26 イヴァン・ペテャエフ 偏性細胞内病原体の治療および診断
US7981606B2 (en) 2005-12-21 2011-07-19 Roche Molecular Systems, Inc. Control for nucleic acid testing
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2009029686A1 (en) 2007-08-27 2009-03-05 Longhorn Vaccines & Diagnostics Llc Immunogenic compositions and methods
ES2552858T3 (es) 2007-10-01 2015-12-02 Longhorn Vaccines And Diagnostics, Llc Recogida de muestras biológicas y sistema de transporte y métodos de uso
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
EP2163239A1 (de) 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
WO2010028366A2 (en) * 2008-09-05 2010-03-11 Life Technologies Corporation Methods and systems for nucleic acid sequencing validation, calibration and normalization
JP5532635B2 (ja) * 2009-03-11 2014-06-25 凸版印刷株式会社 核酸含有リポソームを用いた遺伝子解析方法及び遺伝子解析キット
WO2011103467A2 (en) 2010-02-19 2011-08-25 Life Technologies Corporation Methods and systems for nucleic acid sequencing validation, calibration and normalization
EP2602331A1 (en) * 2011-12-09 2013-06-12 Qiagen GmbH Diagnostic reagent embedded in wax as an internal standard for nucleic acid preparation or nucleic acid detection
EP2806890A4 (en) 2012-01-26 2015-09-02 Longhorn Vaccines & Diagnostics Llc COMPOSITE ANTIGENIC SEQUENCES AND VACCINES
WO2014187878A1 (en) * 2013-05-21 2014-11-27 Institut National De La Sante Et De La Recherche Medicale (Inserm) Internal dna standards for assays using micro-electrophoresis
EP3292221B1 (en) * 2015-05-06 2021-06-23 Seracare Life Sciences Inc. Liposomal preparations for non-invasive-prenatal or cancer screening
US9976136B2 (en) 2015-05-14 2018-05-22 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
WO2022045009A1 (ja) * 2020-08-24 2022-03-03 国立大学法人山口大学 流体を追跡するための組成物及び流体の追跡方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
EP0348458B1 (en) * 1987-11-30 1997-04-09 University Of Iowa Research Foundation Dna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5622820A (en) * 1988-03-10 1997-04-22 City Of Hope Method for amplification and detection of RNA and DNA sequences
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5652122A (en) * 1989-12-21 1997-07-29 Frankel; Alan Nucleic acids encoding and methods of making tat-derived transport polypeptides
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US5703221A (en) * 1991-05-23 1997-12-30 Martin; William John Stealth virus nucleic acids and related methods
DE69221118T2 (de) * 1992-02-25 1998-02-26 Stephen C Wardlaw Zielkomponenten-Assay
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5766627A (en) * 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
US5814442A (en) * 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5612473A (en) * 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
US5697409A (en) * 1996-02-21 1997-12-16 Biomerieux Vitek, Inc. Diluting and pipetting stations for sample testing machine
US5670375A (en) * 1996-02-21 1997-09-23 Biomerieux Vitek, Inc. Sample card transport method for biological sample testing machine
US5674454A (en) * 1996-02-21 1997-10-07 Bio Merieux Vitek, Inc. Stacking disposal system for test sample cards or other similarly shaped objects
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US5792851A (en) * 1996-09-03 1998-08-11 Albert Einstin College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Human prostaglandin transporter
US5786182A (en) * 1997-05-02 1998-07-28 Biomerieux Vitek, Inc. Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making

Also Published As

Publication number Publication date
AU2001284203B2 (en) 2007-03-15
GB0021303D0 (en) 2000-10-18
WO2002018635A2 (en) 2002-03-07
JP4504618B2 (ja) 2010-07-14
EP1320631A2 (en) 2003-06-25
AU8420301A (en) 2002-03-13
US20110065092A1 (en) 2011-03-17
WO2002018635A3 (en) 2003-03-20
US20040101869A1 (en) 2004-05-27
NO325465B1 (no) 2008-05-05
NO20030917L (no) 2003-04-16
JP2004513624A (ja) 2004-05-13
NZ524881A (en) 2004-12-24
WO2002018635A8 (en) 2003-12-31
CA2420845A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
ATA2932001A (de) Schneefräse
DE50102988D1 (de) Bodenwischer
DE60125415D1 (de) Formeinsatz
NO20030917D0 (no) Anvendelse
DE50100710D1 (de) Wischblatt
ATE298751T1 (de) 7-oxopyridoryrimidine
ATE262530T1 (de) Indolochinazolinone
DE1274523T1 (de) Hochdruckumformspülanlage
DE10192638T1 (de) Bohrstangenladevorrichtung
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
DE50011511D1 (de) Blowby-Heizung
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
DE10052925B4 (de) Schaukelbett
ATE476423T1 (de) Benzoylpyridazine
DE50007634D1 (de) Kardioplegieballonkatheter
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees